AU2018364335A1 - ERGIC1 as epigenetic marker for the identification of immune cells, in particular monocytic myeloid-derived suppressor cells (mMDSCs) - Google Patents

ERGIC1 as epigenetic marker for the identification of immune cells, in particular monocytic myeloid-derived suppressor cells (mMDSCs) Download PDF

Info

Publication number
AU2018364335A1
AU2018364335A1 AU2018364335A AU2018364335A AU2018364335A1 AU 2018364335 A1 AU2018364335 A1 AU 2018364335A1 AU 2018364335 A AU2018364335 A AU 2018364335A AU 2018364335 A AU2018364335 A AU 2018364335A AU 2018364335 A1 AU2018364335 A1 AU 2018364335A1
Authority
AU
Australia
Prior art keywords
cells
seq
cpg
methylation
region
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2018364335A
Other languages
English (en)
Inventor
Sven Olek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Precision for Medicine GmbH
Original Assignee
Prec For Medicine GmbH
Precision for Medicine GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prec For Medicine GmbH, Precision for Medicine GmbH filed Critical Prec For Medicine GmbH
Publication of AU2018364335A1 publication Critical patent/AU2018364335A1/en
Assigned to PRECISION FOR MEDICINE GMBH reassignment PRECISION FOR MEDICINE GMBH Amend patent request/document other than specification (104) Assignors: EPIONTIS GMBH
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2018364335A 2017-11-09 2018-11-06 ERGIC1 as epigenetic marker for the identification of immune cells, in particular monocytic myeloid-derived suppressor cells (mMDSCs) Abandoned AU2018364335A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102017126248.2 2017-11-09
DE102017126248.2A DE102017126248B4 (de) 2017-11-09 2017-11-09 ERGIC1 als epigenetischer Marker zur Identifizierung von Immunzellen, insbesonderemonozytischem myeloid-abgeleiteten Suppressor-Zellen (mMDSCs)
PCT/EP2018/080235 WO2019091942A1 (en) 2017-11-09 2018-11-06 ERGIC1 AS EPIGENETIC MARKER FOR THE IDENTIFICATION OF IMMUNE CELLS, IN PARTICULAR MONOCYTIC MYELOID-DERIVED SUPPRESSOR CELLS (mMDSCs)

Publications (1)

Publication Number Publication Date
AU2018364335A1 true AU2018364335A1 (en) 2020-05-28

Family

ID=64184067

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2018364335A Abandoned AU2018364335A1 (en) 2017-11-09 2018-11-06 ERGIC1 as epigenetic marker for the identification of immune cells, in particular monocytic myeloid-derived suppressor cells (mMDSCs)

Country Status (7)

Country Link
US (1) US11976327B2 (https=)
EP (1) EP3669005B1 (https=)
JP (1) JP2021502809A (https=)
CN (1) CN111315896A (https=)
AU (1) AU2018364335A1 (https=)
DE (1) DE102017126248B4 (https=)
WO (1) WO2019091942A1 (https=)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2869295A1 (en) 2011-05-25 2012-11-29 Brown University Methods using dna methylation for identifying a cell or a mixture of cells for prognosis and diagnosis of diseases, and for cell remediation therapies
JP6590790B2 (ja) * 2013-04-19 2019-10-16 エピオンティス ゲーエムベーハー 生体サンプルにおける定量的細胞組成を特定する方法
US10190169B2 (en) 2013-06-20 2019-01-29 Immunexpress Pty Ltd Biomarker identification
EP3132055A2 (en) 2014-04-14 2017-02-22 Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd. A method and kit for determining the tissue or cell origin of dna

Also Published As

Publication number Publication date
JP2021502809A (ja) 2021-02-04
DE102017126248B4 (de) 2019-10-17
US20200347453A1 (en) 2020-11-05
CA3082261A1 (en) 2019-05-16
DE102017126248A1 (de) 2019-05-09
CN111315896A (zh) 2020-06-19
WO2019091942A1 (en) 2019-05-16
EP3669005B1 (en) 2026-03-04
US11976327B2 (en) 2024-05-07
EP3669005A1 (en) 2020-06-24

Similar Documents

Publication Publication Date Title
US11643687B2 (en) LRP5 as epigenetic marker for the identification of immune cells, in particular B-cells
CA2999614C (en) Park2 as epigenetic marker for the identification of immune cells, in particular monocytes
EP3353321B1 (en) Mvd as epigenetic marker for the identification of cd56+ nk cells
US20200370117A1 (en) Endosialin (cd248) as epigenetic marker for the identification of immune cells, in particular naïve cd8+ t-cells
US11725243B2 (en) Epigenetic method for the identification of follicular T-helper-(TFH-) cells
US11680294B2 (en) Amplicon region as epigenetic marker for the identification of non-classical monocytes
CA3082261C (en) Ergic1 as epigenetic marker for the identification of immune cells, in particular monocytic myeloid-derived suppressor cells (mmdscs)
US11976327B2 (en) ERGIC1 as epigenetic marker for the identification of immune cells, in particular monocytic myeloid-derived suppressor cells (mMDSCs)
US11597975B2 (en) PDCD1 as epigenetic marker for the identification of immune cells, in particular PD1+ cells
CA3080060C (en) Pdcd1 as epigenetic marker for the identification of immune cells, in particular pd1+ cells
CA2999611C (en) Lrp5 as epigenetic marker for the identification of immune cells, in particular b-cells
EP4720343A1 (en) Lag3 as epigenetic marker for the identification of immune cells
WO2019224014A1 (en) Cxcr3 as epigenetic marker for the identification of inflammatory immune cells, in particular cd8+ memory t cells
HK1257582B (en) Park2 as epigenetic marker for the identification of immune cells, in particular monocytes

Legal Events

Date Code Title Description
HB Alteration of name in register

Owner name: PRECISION FOR MEDICINE GMBH

Free format text: FORMER NAME(S): EPIONTIS GMBH

MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application